Publications
These are key publications from our researchers:
Coleman CM, Sisk JM, Halasz G, Zhong J, Beck SE, Matthews KL, Venkataraman T, Rajagopalan S, Kyratsous CA, and Frieman MB (2016). CD8+ T cells and macrophages regulate pathogenesis in a mouse model of MERS. Journal of Virology. e01825-16
ColemanCM*, Sisk JM*, MingoRM, NelsonEA, WhiteJM and Frieman MB (2016). ABL kinase inhibitors are potent inhibitors of SARS-CoV and MERS-CoV fusion. Journal of Virology. 90: 8924-8933.
Dyall J*, Coleman CM*, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, Johnson RF, Olinger Jr. GG, Jahrling P, Laidlaw M, Johansen LM, Lear CM, Glass PJ, Hensley LE and Frieman MB (2014). Repurposing of clinically developed drugs for treatment of MERS-CoV infection. Antimicrobial Agents and Chemotherapy. 58: 4885-4893.
Coleman CM*, Liu YV*, Mu H, Taylor JK, Massare M, Flyer D, Smith G and Frieman MB (2014). Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine. 32: 3169-3174.
Matthews KL*, Coleman CM*, van de Meer Y, Snijder EJ and Frieman MB (2014). The ORF4b-encoded accessory proteins of MERS-Coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. Journal of General Virology. 95: 874-882.
Coleman CM, Plant K, Newton S, Hobson L, Whyte MK and Everard ML (2011). The anti-apoptotic effect of respiratory syncytial virus on human peripheral blood neutrophils is mediated by a monocyte derived soluble factor. The Open Virology Journal 5: 114-123.
Coleman CM, Spearman P and Wu L (2011). Tetherin does not significantly restrict dendritic cell mediated transmission of HIV-1 and its expression is upregulated by newly synthesized HIV-1 Nef. Retrovirology 8: 26